ADVFN - ニュース

S&P 500

5,477.90

0.16%

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

該当コードがありません。

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/27	05 : 54	PR Newswire (US)	Select Medical Holdings Corporation and Concentra Group Holdings Parent, Inc. Announce Pricing of Offering of $650 Million of 6.875% Senior Notes due 2032 by Concentra Escrow Issuer Corporation	NYSE:SEM	Select Medical Holdings Corporation
2024/06/27	05 : 53	GlobeNewswire Inc.	OV Entertainment Group Acquires Brazilian Studio Kokku Games and Argentinian Studio 3OGS
2024/06/27	05 : 53	Business Wire	Vitruvian Partners accroît sa participation dans Civitatis
2024/06/27	05 : 52	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:AMJ	JP Morgan Alerian MLP
2024/06/27	05 : 52	Business Wire	Altria Announces PMTA Submission for on! PLUS™ Nicotine Pouches	NYSE:MO	Altria Group Inc
2024/06/27	05 : 50	Business Wire	More than 700 Youth Volleyball Teams Compete at LA Convention Center for SoCal Cup’s ‘The Showcase’ Tournament
2024/06/27	05 : 49	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:AMJ	JP Morgan Alerian MLP
2024/06/27	05 : 49	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	NYSE:GS-J	Goldman Sachs Group Inc
2024/06/27	05 : 49	PR Newswire (Canada)	Nominations du Conseil des ministres
2024/06/27	05 : 48	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:AMJ	JP Morgan Alerian MLP
2024/06/27	05 : 48	Business Wire	Venture West Funding Facilitates $30.25 Million Loan for Luxury Apartment Building Refinance in Hollywood, CA
2024/06/27	05 : 47	GlobeNewswire Inc.	Oragenics, Inc. Announces Closing of Public Offering	AMEX:OGEN	Oragenics Inc
2024/06/27	05 : 47	GlobeNewswire Inc.	Moms For America Sues to Overturn Big Pharma Immunity
2024/06/27	05 : 45	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	USOTC:BMOLF	Bank of Montreal (PK)
2024/06/27	05 : 45	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:AMJ	JP Morgan Alerian MLP
2024/06/27	05 : 45	Alliance News	TOP NEWS: Micron shares drop despite solid third quarter growth	TG:MTE	Micron Technology Inc
2024/06/27	05 : 45	GlobeNewswire Inc.	Applications Now Open for HII’s Ingalls Shipbuilding STEM Grant Awards	NYSE:HII	Huntington Ingalls Industries Inc
2024/06/27	05 : 45	Business Wire	Geospace Technologies Joins Russell 2000®, Russell 3000® and Russell Micro-Cap Indexes	NASDAQ:GEOS	Geospace Technologies Corporation
2024/06/27	05 : 45	PR Newswire (US)	ANTERIX TO RELEASE FOURTH-QUARTER EARNINGS FOR FISCAL 2024, HOLD ANALYST AND INVESTOR CALL	NASDAQ:ATEX	Anterix Inc
2024/06/27	05 : 45	PR Newswire (US)	Anterix Reports Fourth Quarter and Full Fiscal Year 2024 Results	NASDAQ:ATEX	Anterix Inc
2024/06/27	05 : 45	PR Newswire (US)	Maverick Public Relations Amps Up Its Media Training offerings with the Addition of Award-Winning Broadcast Journalism Pro
2024/06/27	05 : 43	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	USOTC:RYBPF	Royal Bank (PK)
2024/06/27	05 : 42	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	NYSE:GS-J	Goldman Sachs Group Inc
2024/06/27	05 : 42	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	USOTC:BMOLF	Bank of Montreal (PK)
2024/06/27	05 : 41	GlobeNewswire Inc.	Transforming Cancer Care: Novotech Releases Report on Radiopharmaceuticals Global Clinical Trials Landscape
2024/06/27	05 : 41	GlobeNewswire Inc.	Transforming Cancer Care: Novotech Releases Report on Radiopharmaceuticals Global Clinical Trials Landscape
2024/06/27	05 : 41	PR Newswire (US)	Republic of Peru Announces Results of Stand-Alone Tender Offers
2024/06/27	05 : 40	GlobeNewswire Inc.	Tonix Pharmaceuticals Announces Proposed Public Offering	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/06/27	05 : 40	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BSGM	BioSig Technologies Inc
2024/06/27	05 : 39	GlobeNewswire Inc.	NeOnc Technologies Completes $18.5 Million Financing, Advances Phase II Clinical Trials for Enhanced Method of Delivering Novel Therapeutics to the Brain Under FDA Fast-Track Status	NTHI